nodes	percent_of_prediction	percent_of_DWPC	metapath
Norgestimate—ABCC2—Vincristine—sarcoma	0.33	0.393	CbGbCtD
Norgestimate—ABCC2—Etoposide—sarcoma	0.302	0.361	CbGbCtD
Norgestimate—ABCC2—Doxorubicin—sarcoma	0.206	0.246	CbGbCtD
Norgestimate—ESR1—periosteum—sarcoma	0.0151	0.198	CbGeAlD
Norgestimate—PGR—Ovarian Infertility Genes—GJA4—sarcoma	0.00747	0.0874	CbGpPWpGaD
Norgestimate—PGR—mammary gland—sarcoma	0.00573	0.0754	CbGeAlD
Norgestimate—ESR1—mammary gland—sarcoma	0.00448	0.0589	CbGeAlD
Norgestimate—PGR—myometrium—sarcoma	0.00406	0.0535	CbGeAlD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.0037	0.0434	CbGpPWpGaD
Norgestimate—PGR—hematopoietic system—sarcoma	0.00349	0.0459	CbGeAlD
Norgestimate—PGR—connective tissue—sarcoma	0.00336	0.0442	CbGeAlD
Norgestimate—ESR1—myometrium—sarcoma	0.00318	0.0418	CbGeAlD
Norgestimate—ESR1—LKB1 signaling events—EZR—sarcoma	0.00308	0.0361	CbGpPWpGaD
Norgestimate—PGR—smooth muscle tissue—sarcoma	0.00307	0.0404	CbGeAlD
Norgestimate—ESR1—embryo—sarcoma	0.00306	0.0402	CbGeAlD
Norgestimate—ESR1—FOXA1 transcription factor network—COL18A1—sarcoma	0.00293	0.0343	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.00276	0.0323	CbGpPWpGaD
Norgestimate—ESR1—hematopoietic system—sarcoma	0.00273	0.0359	CbGeAlD
Norgestimate—PGR—uterus—sarcoma	0.00264	0.0347	CbGeAlD
Norgestimate—ESR1—connective tissue—sarcoma	0.00263	0.0346	CbGeAlD
Norgestimate—PGR—lymphoid tissue—sarcoma	0.00246	0.0323	CbGeAlD
Norgestimate—ESR1—smooth muscle tissue—sarcoma	0.0024	0.0316	CbGeAlD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00217	0.0254	CbGpPWpGaD
Norgestimate—ESR1—uterus—sarcoma	0.00206	0.0271	CbGeAlD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.00199	0.0233	CbGpPWpGaD
Norgestimate—ABCC2—tendon—sarcoma	0.00198	0.0261	CbGeAlD
Norgestimate—ESR1—lymphoid tissue—sarcoma	0.00192	0.0253	CbGeAlD
Norgestimate—PGR—testis—sarcoma	0.00191	0.0252	CbGeAlD
Norgestimate—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.0018	0.0211	CbGpPWpGaD
Norgestimate—ESR1—Estrogen Receptor Pathway—JUN—sarcoma	0.00171	0.0201	CbGpPWpGaD
Norgestimate—ABCC2—testis—sarcoma	0.00164	0.0216	CbGeAlD
Norgestimate—ESR1—Regulation of Telomerase—WT1—sarcoma	0.00162	0.019	CbGpPWpGaD
Norgestimate—ABCC2—liver—sarcoma	0.00155	0.0204	CbGeAlD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.00151	0.0177	CbGpPWpGaD
Norgestimate—ESR1—Estrogen signaling pathway—CREB1—sarcoma	0.00151	0.0177	CbGpPWpGaD
Norgestimate—ESR1—testis—sarcoma	0.0015	0.0197	CbGeAlD
Norgestimate—ESR1—liver—sarcoma	0.00141	0.0186	CbGeAlD
Norgestimate—PGR—lymph node—sarcoma	0.00139	0.0182	CbGeAlD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.00138	0.0161	CbGpPWpGaD
Norgestimate—ABCC2—lymph node—sarcoma	0.00119	0.0157	CbGeAlD
Norgestimate—ESR1—Leptin signaling pathway—PLCG1—sarcoma	0.00114	0.0133	CbGpPWpGaD
Norgestimate—ESR1—Estrogen signaling pathway—JUN—sarcoma	0.00109	0.0127	CbGpPWpGaD
Norgestimate—ESR1—lymph node—sarcoma	0.00108	0.0143	CbGeAlD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.00108	0.0126	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—PDGFRA—sarcoma	0.000963	0.0113	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—CREB1—sarcoma	0.000915	0.0107	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.000885	0.0104	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—MMP2—sarcoma	0.000868	0.0102	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000818	0.00958	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000816	0.00956	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—FOXO1—sarcoma	0.000809	0.00947	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—FOXO1—sarcoma	0.000783	0.00917	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PDGFRB—sarcoma	0.000782	0.00915	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.000776	0.00909	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PDGFRA—sarcoma	0.000769	0.00901	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.00076	0.00891	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—CREB1—sarcoma	0.000711	0.00832	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000709	0.0083	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—CCND1—sarcoma	0.000672	0.00787	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—MMP2—sarcoma	0.000662	0.00775	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000656	0.00768	CbGpPWpGaD
Norgestimate—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.000646	0.00757	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.00062	0.00726	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000619	0.00724	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000613	0.00718	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—KIT—sarcoma	0.000597	0.00699	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.00059	0.00691	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.000587	0.00687	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—CREB1—sarcoma	0.000568	0.00665	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000559	0.00655	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000551	0.00646	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000545	0.00638	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.000539	0.00631	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000538	0.0063	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—MYC—sarcoma	0.000529	0.0062	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000512	0.006	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	0.000512	0.006	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.000511	0.00599	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000508	0.00595	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—FUS—sarcoma	0.000503	0.00589	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000501	0.00587	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.00049	0.00574	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.00048	0.00562	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000479	0.00561	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—MDM2—sarcoma	0.00047	0.0055	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—IL2—sarcoma	0.000469	0.00549	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000463	0.00542	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000462	0.00541	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.00046	0.00538	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.000459	0.00537	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.000458	0.00537	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.000457	0.00535	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—JUN—sarcoma	0.000456	0.00534	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000452	0.00529	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.000447	0.00523	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000446	0.00522	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000442	0.00518	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—TP53—sarcoma	0.000434	0.00509	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000432	0.00506	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000423	0.00495	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000397	0.00464	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000394	0.00461	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000385	0.00451	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000378	0.00443	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000376	0.00441	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—MYC—sarcoma	0.000367	0.00429	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000359	0.0042	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000358	0.0042	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—NRAS—sarcoma	0.000352	0.00413	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—KIT—sarcoma	0.00035	0.0041	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000335	0.00392	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.000333	0.0039	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—EGFR—sarcoma	0.000321	0.00376	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000319	0.00373	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—KRAS—sarcoma	0.000303	0.00355	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—FUS—sarcoma	0.000295	0.00346	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—TP53—sarcoma	0.000294	0.00345	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000278	0.00325	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000277	0.00325	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—MDM2—sarcoma	0.000276	0.00323	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—HRAS—sarcoma	0.000266	0.00312	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—HRAS—sarcoma	0.000258	0.00302	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000241	0.00283	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000241	0.00282	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000239	0.0028	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00023	0.00269	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TLE1—sarcoma	0.000216	0.00253	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000211	0.00247	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—NRAS—sarcoma	0.000207	0.00242	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.0002	0.00234	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.0002	0.00234	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000198	0.00232	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000194	0.00227	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000189	0.00222	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—EGFR—sarcoma	0.000188	0.00221	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—VEGFC—sarcoma	0.000182	0.00213	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000179	0.0021	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000179	0.0021	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—KRAS—sarcoma	0.000178	0.00209	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000174	0.00204	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.00016	0.00188	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000159	0.00186	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000157	0.00184	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—HRAS—sarcoma	0.000151	0.00177	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000148	0.00174	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FLT1—sarcoma	0.000145	0.0017	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PLCG1—sarcoma	0.000143	0.00167	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CXCR4—sarcoma	0.000137	0.00161	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—MYC—sarcoma	0.000136	0.00159	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ATF1—sarcoma	0.000136	0.00159	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000132	0.00154	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TLE1—sarcoma	0.000127	0.00148	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFC—sarcoma	0.000107	0.00125	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IGF1R—sarcoma	0.000107	0.00125	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FOXO1—sarcoma	0.000101	0.00119	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PDGFRB—sarcoma	0.000101	0.00119	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PDGFRA—sarcoma	9.97e-05	0.00117	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FLT1—sarcoma	8.53e-05	0.001	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PLCG1—sarcoma	8.39e-05	0.000983	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KDR—sarcoma	8.39e-05	0.000983	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCR4—sarcoma	8.06e-05	0.000944	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—MYC—sarcoma	7.97e-05	0.000934	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ATF1—sarcoma	7.97e-05	0.000933	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KIT—sarcoma	7.73e-05	0.000905	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CREB1—sarcoma	7.36e-05	0.000862	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—MYC—sarcoma	6.54e-05	0.000766	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IGF1R—sarcoma	6.25e-05	0.000732	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MDM2—sarcoma	6.09e-05	0.000713	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FOXO1—sarcoma	5.95e-05	0.000697	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PDGFRB—sarcoma	5.94e-05	0.000696	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PDGFRA—sarcoma	5.85e-05	0.000685	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IL2—sarcoma	5.44e-05	0.000637	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CCND1—sarcoma	5.3e-05	0.000621	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—JUN—sarcoma	5.29e-05	0.00062	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CTNNB1—sarcoma	5.25e-05	0.000615	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KDR—sarcoma	4.92e-05	0.000577	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SRC—sarcoma	4.75e-05	0.000556	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—VEGFA—sarcoma	4.62e-05	0.000541	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NRAS—sarcoma	4.57e-05	0.000535	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KIT—sarcoma	4.54e-05	0.000531	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CREB1—sarcoma	4.32e-05	0.000506	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MYC—sarcoma	4.25e-05	0.000498	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—EGFR—sarcoma	4.16e-05	0.000487	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KRAS—sarcoma	3.93e-05	0.00046	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—MYC—sarcoma	3.84e-05	0.00045	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MDM2—sarcoma	3.57e-05	0.000418	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TP53—sarcoma	3.49e-05	0.000409	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HRAS—sarcoma	3.34e-05	0.000391	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IL2—sarcoma	3.19e-05	0.000374	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CCND1—sarcoma	3.11e-05	0.000364	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—JUN—sarcoma	3.1e-05	0.000364	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CTNNB1—sarcoma	3.08e-05	0.000361	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SRC—sarcoma	2.79e-05	0.000326	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFA—sarcoma	2.71e-05	0.000318	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NRAS—sarcoma	2.68e-05	0.000314	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MYC—sarcoma	2.5e-05	0.000292	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EGFR—sarcoma	2.44e-05	0.000286	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KRAS—sarcoma	2.31e-05	0.00027	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TP53—sarcoma	2.05e-05	0.00024	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HRAS—sarcoma	1.96e-05	0.00023	CbGpPWpGaD
